Akeso Medical Holdings, LLC
Akeso Medical Holdings, LLC, headquartered in the United States, is a prominent player in the biopharmaceutical industry, specialising in innovative therapies for autoimmune diseases and cancer. Founded in 2010, the company has achieved significant milestones, including the development of cutting-edge monoclonal antibodies that target specific disease pathways, setting it apart in a competitive market. With a strong operational presence across North America and Asia, Akeso is dedicated to advancing healthcare through its unique product offerings, which include both proprietary drugs and collaborative research initiatives. The company’s commitment to scientific excellence has positioned it as a leader in the biopharmaceutical sector, recognised for its contributions to improving patient outcomes and enhancing treatment options.
DitchCarbon Score
How does Akeso Medical Holdings, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Akeso Medical Holdings, LLC's score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Akeso Medical Holdings, LLC's reported carbon emissions
Akeso Medical Holdings, LLC, headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no defined reduction targets or climate commitments outlined by the company at this time. In the absence of concrete emissions data, it is unclear how Akeso Medical Holdings is addressing climate change or its carbon footprint within the industry context. As the company moves forward, establishing measurable climate commitments and reduction initiatives will be essential for aligning with industry standards and addressing environmental sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Akeso Medical Holdings, LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
